Results 161 to 170 of about 12,288 (265)

Review of: "Immunogenicity and reactogenicity after booster dose with AZD1222 via intradermal route among adult who had received CoronaVac" [PDF]

, 2021
Yotam Levin
openalex   +1 more source

Thrombocytopenia and venous thromboembolic events after BNT162b2, CoronaVac, ChAdOx1 vaccines and SARS-CoV-2 infection: a self-controlled case series study [PDF]

, 2023
Norazida Ab Rahman, Ming Tsuey Lim, Fei Yee Lee, Wee Kee Wo, Hee Sheong Yeoh, Kalaiarasu M. Peariasamy, Sheamini Sivasampu, the SAFECOVAC Study Group, Azuana Ramli, Sing Chet Lee, Sim Mei Choo, Maheshwara Rao Appanan, Teck Long King, Chia How Yen, Emelyne Bani Anak Jam, Fatihah Mahmud, Fariz Safhan Mohamad Nor, Muhammad Hazrul Badrul Hisham, Siti Nurhafizah Saharudin, Nor Aliya Ayub, Raj Kumar Sevalingam, Rashidah Bahari, Nor Nadziroh Ibrahim, Nurain Mohd Noor, Lisa Mohamed Nor, Nurul Huda Zainal Abidin, Hin Seng Wong, Siti Nur Akmal Ghazali, Nurul Afifah Rozkhaidi, Norzubaidatulhikmah Shaduqi, Hanisah Hossain, Jeannette Jieni Lay, Nor Azizah Mohamad Nazri   +32 more
openalex   +1 more source

Effect of Heterologous Vaccination Strategy on Humoral Response against COVID-19 with CoronaVac Plus BNT162b2: A Prospective Cohort Study

, 2022
Hakan Demırhındı, Burak Mete, Ferdi Tanır, Ertan Kara, Filiz Kibar, Sali̇h Çeti̇ner, Aslıhan Candevir, Sukriye Ece Akti   +7 more
openalex   +2 more sources

Referee report. For: Waning anti-SARS-CoV-2 neutralizing antibody in CoronaVac-vaccinated individuals in Indonesia [version 1; peer review: 1 approved with reservations, 1 not approved]

, 2022
Ritthideach Yorsaeng
openalex   +1 more source

Level of SARS-CoV-2 IgG antibodies after two doses CoronaVac vaccine: Primarily report [PDF]

, 2021
Umut Devrim Binay, Faruk Karakeçili, Orçun Barkay, Özlem Gül, Cuma Mertoğlu   +4 more
openalex   +1 more source

Anti-SARS-CoV-2 immunogenicity decay and incident cases six months after Sinovac-CoronaVac inactivated vaccine in autoimmune rheumatic diseases patients: phase 4 prospective trial [PDF]

, 2021
Eloísa Bonfá, Clóvis A. Silva, Ana Cristina de Medeiros Ribeiro, Léonard de Vinci Kanda Kupa, Emily Figueiredo Neves Yuki, Sandra Sandra G. Pasoto, Carla Gonçalves Schahin Saad, Solange Fusco, Rosa Maria Rodrigues Pereira, Samuel Katsuyuki Shinjo, Ari Stiel Radu Halpern, Eduardo Ferreira Borba, Fernando Henrique Carlos de Souza, Lissiane Guedes, Renata Miossi, Karina Rossi Bonfiglioli, Diogo Souza Domiciano, Andrea Yukie Shimabuco, Danieli Andrade, Luciana Parente Costa Seguro, Ricardo Fuller, Percival D. Sampaio‐Barros, Ana Paula Luppino Assad, Júlio César Bertacini de Moraes, Cláudia Goldenstein‐Schainberg, Henrique Ayres Mayrink Giardini, Henrique Silva, Victor A. O. Martins, Lorena Elizabeth Betancourt Villamarín, Renata Soares, Lucas Peixoto Sales, Carlo Scognamiglio Renner Araújo, Matheus Silva, Dilson M. N. Filho, Marta Heloísa Lopes, Alberto Duarte, Alberto Duarte, Esper G. Kallás, Esper G. Kallás, Nádia Emi Aikawa   +39 more
openalex   +1 more source

OS ASPECTOS DA VACINA CORONAVAC CONTRA COVID-19 [PDF]

ANAIS DO II CONGRESSO NORTE-NORDESTE DE SAÚDE PÚBLICA (ON LINE) RESUMOS EXPANDIDOS, 2021
openaire   +1 more source

Safety and Immunogenicity of Intradermal Administration of Fractional Dose CoronaVac ^® , ChAdOx1 nCoV-19 and BNT162b2 as Primary Series Vaccination [PDF]

, 2022
Somruedee Chatsiricharoenkul, Suvimol Niyomnaitham, Harry Joshua Posen, Zheng Quan Toh, Paul V. Licciardi, Patimaporn Wongprompitak, Thaneeya Duangchinda, Pattarakul Pakchotanon, Warangkana Chantima, Kulkanya Chokephaibulkit   +9 more
openalex   +1 more source

A mortal Covid-19 case with SARS-CoV-2 variant VOC-202012/01 after two doses of CoronaVac® vaccination, case report

, 2022
Mehmet Muzaffer İslam, Enis Ademoğlu, Samet BAYRAM, Merve Osoydan Satıcı, Serkan Emre Eroğlu   +4 more
openalex   +1 more source

Resposta imune humoral anti-SARS-CoV-2 para diferentes cepas virais após vacinação completa com Sinovac-CoronaVac e Oxford/AstraZeneca (ChAdOx1-S) em uma população de trabalhadores da saúde no Brasil [PDF]

COVID-19, caused by the SARS-CoV-2 virus, is a global respiratory syndrome with high mortality rates. Vaccination is currently the only proven method to prevent the disease, although the role of lab data in assessing efficacy remains uncertain.
Barioni, Éric Diego, Carvalho, Flavia Cristina Cardoso, Loiola, Rodrigo Azevedo, Mahelly Bueno de Almeida, Nascimento, Beatriz Birelli do, Oliveira, Fernanda de Assis, Oliveira, Maicon Jeferson Silva de, Oliveira, Rômulo Tadeu Dias de, Rocha, Gustavo Henrique Oliveira da, Rodrigues, Márcio   +9 more
core   +1 more source